This episode is part of ACC's ongoing initiative to recognize the risks and tackle management of Hypertriglyceridemia (HTG) and Severe Hypertriglyceridemia (sHTG). Drs. Michael Miller and Monica Aggarwal review and emphasize the need to understand the multifactorial and genetic causes of HTG and sHTG, as well as the associated risks of pancreatitis and ASCVD.

This podcast is part of the ACC's Hypertriglyceridemia and Cardiovascular Health: Recognizing Risks and Tackling Management initiative, supported by Ionis Pharmaceuticals.

This episode is part of ACC's ongoing educational initiative to enhance the recognition, diagnosis, and management of paroxysmal supraventricular tachycardia (PSVT). Faculty review contemporary acute treatment approaches, including established therapies, recent advances, and first-line emergency department strategies with attention to efficacy and safety. The discussion also addresses management of refractory or recurrent cases, decision-making across diverse patient populations and care settings, and criteria for hospital admission versus discharge. Additionally, it provides practical guidance on patient education, symptom recognition, and selecting treatments that balance effectiveness, safety, convenience, and patient confidence.

This podcast is part of the ACC's educational initiative on PSVT, supported by an independent educational grant from Milestone Pharmaceuticals Inc. Click here to learn more.

This episode provides a team-based overview of diagnosing and managing acute paroxysmal supraventricular tachycardia (PSVT) across care settings. It emphasizes how patients interact with providers from primary care to electrophysiology and the importance of coordinated roles. The discussion highlights shared decision-making and targeted education to help patients recognize symptoms, understand recurrence risk, and respond to episodes. Key topics include when to seek care, initial self-management steps, and long-term options such as medication, ablation, or observation. It also reviews practical action plans and the role of newer therapies like intranasal etripamil in individualized care.

This podcast is part of the ACC's educational initiative on PSVT, supported by an independent educational grant from Milestone Pharmaceuticals Inc. Click here to learn more: https://learn.acc.org/Page/LearnSVT

This episode is part of ACC's ongoing initiative to advance education on remote hemodynamic monitoring in heart failure management. Drs. Vishal Rao and Sandip Zalawadiya, along with Ms. Lisa Rathman, CRNP, discuss patient cases highlighting both successful pulmonary artery (PA) pressure device implantation and associated complications. They emphasize key practical considerations, including device placement, patient selection, waveform accuracy, troubleshooting, and team coordination during the procedure.

This podcast is part of the ACC's Pulmonary Artery Pressure Monitoring: Transforming HF Patient Care initiative, supported by Abbott. 

This episode is part of ACC's ongoing effort to improve recognition and diagnosis of arrhythmias in clinical practice. In this CardiaCast, faculty explore a modern approach to identifying paroxysmal supraventricular tachycardia (PSVT), with a focus on real-world diagnostic challenges. The discussion highlights how to differentiate PSVT from other common causes of palpitations, interpret normal electrocardiograms between episodes, and recognize patterns that may be misattributed to anxiety, particularly in otherwise healthy patients. The episode also reviews practical strategies for rhythm capture, including ambulatory monitoring and patient-directed documentation, to support timely and accurate diagnosis.

This podcast is part of the ACC's educational initiative on PSVT, supported by an independent educational grant from Milestone Pharmaceuticals Inc. Click here to learn more: https://learn.acc.org/Page/LearnSVT

In this episode, hosts Rosy Thachil, MD, FACC, and Shashank Sinha, MD, FACC, are joined by Jacob Jentzer, MD, FACC, and Ami Bhatt, MD, FACC, Chief Innovation Officer of the American College of Cardiology, for an engaging discussion on AI in the CICU: Transforming Cardiac Critical Care. The conversation explores how artificial intelligence (AI) is beginning to reshape cardiac critical care—from improving clinical decision support and hemodynamic monitoring to predict patient deterioration and optimizing CICU workflows. The panel also discusses the opportunities and challenges of integrating AI into everyday practice and what the future may hold for clinicians caring for the sickest cardiovascular patients.

This CardiaCast episode explores the latest advances in transthyretin amyloid cardiomyopathy (ATTR-CM) presented at ACC.26, with a focused review of newly released late-stage clinical trial data for currently available disease-modifying therapies. Expert faculty Drs. Sarah Cuddy and Prem Soman break down how emerging evidence is reshaping treatment selection, including considerations for efficacy, safety, and patient-specific factors. The discussion highlights practical strategies for integrating these new findings into real-world clinical practice to optimize outcomes for patients with ATTR-CM.

This podcast is developed by the American College of Cardiology Foundation and Med-IQ and supported by an educational grant from Bridge Bio.

In this episode of CardiaCast, Dr. Michael Blaha will be joined by Dr. Ann Marie Navar to discuss the 2026 updates to ACC/AHA guideline on management of dyslipidemia and key clinical trial data supporting the use of PCSK9 inhibitors in getting patients to their lipid goals. They discuss available PCSK9 inhibitors, including the recently approved injectable PCSK9 inhibitor lerodalcibep-liga. After discussing the limitations and barriers associated with injectable PCSK9 inhibitors, they will introduce the emerging oral PCSK9 inhibitors and explore the latest clinical data for enlicitide and AZD0780.

This podcast was developed by the American College of Cardiology Foundation and Med-IQ and supported by an educational grant from Merck.